 | |
 | |
| Clinical data | |
|---|---|
| Other names | BU-LAD; BULAD; 6-Butyl-6-nor-LSD; 6-Butyl-6-nor-Lysergic acid diethylamide |
| Routes of administration | Oral[1] |
| Drug class | Serotonergic psychedelic;Hallucinogen |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C23H31N3O |
| Molar mass | 365.521 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
BU-LAD, also known as6-butyl-6-nor-LSD or6-butyl-6-nor-lysergic acid diethylamide, is apsychedelic drug andanalogue oflysergic acid diethylamide (LSD) first described byDavid E. Nichols and colleagues in the 1980s.[2][3]
According toAlexander Shulgin in his bookTiHKAL (Tryptamines I Have Known and Loved), BU-LAD is apsychedelic drug similar to LSD, but is significantly lesspotent than LSD, with a dose of 500 μgorally producing only mild effects.[1]
Analogues of BU-LAD includeLSD,ETH-LAD,PRO-LAD,AL-LAD,PARGY-LAD, andMAL-LAD, among others.
TABLE 1 Effects of N-(6)-Alkyl Subtituents on LSD-Like Behavior and Serotonin Receptor Affinity in Rats [...]
